Immunicom is a biotechnology company.
Immunicom has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in June 2022.
Immunicom's investors include National Institutes of Health, National Cancer Institute.
Immunicom is headquartered in San Diego, United States.
Immunicom is a biotechnology company.
Immunicom is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immunicom — Funding & Investors." VCBacked, June 14, 2022, https://www.vcbacked.co/company/immunicom. Accessed October 31, 2026.
VCBacked. (2022). Immunicom — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/immunicom
{{cite web |title=Immunicom — Funding & Investors |url=https://www.vcbacked.co/company/immunicom |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated